Placebo-forte

M. Spitzer

doi:10.1055/s-0038-1627639

Nervenheilkunde, Table of Contents

Nervenheilkunde 2015; 34(11): 923-927
DOI: 10.1055/s-0038-1627639

Geist & Gehirn

Schattauer GmbH

Placebo-forte

M. Spitzer Ulm

Abstract

Full Text

References

Literatur
1 Anchisi D, Zanon M. A Bayesian perspective on sensory and cognitive integration in pain perception and placebo analgesia. PLoS ONE 2015; 10 (02) e0117270.
2 Anlauf M, Hein L, Hense HW, Köbberling J, Lasek R, Leidl R, Schöne-Seifert B. Complementary and alternative drug therapy versus science-oriented medicine. Ger Med Sci 2015; 13: pDoc05.
3 Atlas LY, Bolger N, Lindquist MA, Wager TD. Brain mediators of predictive cue effects on perceived pain. The Journal of Neuroscience 2010; 30: 12964-12977.
4 Atlas LY, Wager TD. How expectations shape pain. Neuroscience Letters 2012; 520: 140-148.
5 Beecher H. Relationship of significance of wound to pain experienced. JAMA 1956; 161: 1609-1613.
6 Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 1996; 64: 535-543.
7 Benedetti F. No prefrontal control, no placebo response. Pain 2010; 148: 357-358.
8 Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med 2011; 17: 1228-1230.
9 Benedetti F, Arduino C, Costa S, Vighetti S, Tarenzi L, Rainero I. et al. Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective. Pain 2006; 121: 133-144.
10 Benedetti F, Carlino E, Pollo A. How placebos change the patient’s brain. Neuropsy-chopharmacology Reviews 2011; 36: 339-354.
11 Bernateck M, Karst M, Eberhard S, Vivell W, Fischer MJ, Stichtenoth DO. Analyse von Umfang und Erwartung in einer Klinik der Maximalversorgung. Der Schmerz 2009; 23: 47-53.
12 Bosch OJ, Neumann ID. Brain vasopressin is an important regulator of maternal behavior independent of dams’ trait anxiety. PNAS 2008; 105: 17139-17144.
13 Büchel C, Geuter S, Sprenger C, Eippert F. Placebo analgesia: A predictive coding perspective. Neuron 2014; 81: 1223-1239.
14 Bundesätztekammer (Hrsg.). Placebo in der Medizin. Köln: Deutscher Ärzteverlag. 2010
15 Cho MM, DeVries AC, Williams JR, Carter CS. The effects of oxytocin and vasopressin on partner preferences in male and female prairie voles (Microtus ochrogaster). Behav Neurosci 1999; 1113: 1071-1079.
16 Colloca L, Grillon C. Understanding placebo and nocebo responses for pain management. Curr Pain Headache Rep 2014; 18: 419.
17 Colloca L, Pine DS, Ernst M, Miller FG, Grillon C. Vasopressin boosts placebo analgesic effects in women: A randomized trial. Biol Psychiatry 2015 Aug 4. pii: S0006-3223(15)00638-1.
18 Donaldson ZR, Young LJ. Oxytocin, vasopressin, and the neurogenetics of sociality. Science 2008; 322: 900-904.
19 Eippert F, Finsterbusch J, Bingel U, Büchel C. Direct evidence for spinal cord involvement in placebo analgesia. Science 2009; 326: 404.
20 Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet 2010; 375: 686-695.
21 Hebb DO. The organization of behavior. New York: Wiley; 1949
22 Jepma M, Wagner TD. Conceptual conditioning: Mechanisms mediating conditioning effects on pain. Psychological Science. 2015 doi:10.1177/ 0956797615597658.
23 Jütte R. et al. Stellungnahme des Wissenschaftlichen Beirats der Bundesärztekammer “Placebo in der Medizin”. Deutsches Ärzteblatt 2010; 107: A1417-A1421.
24 Kaptchuk TJ. et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. British Medical Journal. 2008 doi:10.1136/bmj.39524.439618.25.
25 Kessner S, Sprenger C, Wrobel N, Wiech K, Bingel U. Effect of oxytocin on placebo analgesia: a randomized study. JAMA 2013; 310: 1733-1735.
26 Krummenacher P, Candia V, Folkers G, Schedlowski M, Schönbaächler G. Prefrontal cortex modulates placebo analgesia. Pain 2010; 148: 368-374.
27 Levine JD, Gordon NC, Fields HL. The mechanisms of placebo analgesia. Lancet 1978; 312: 654-657.
28 Melzack R, Wall PD, Ty TC. Acute pain in an emergency clinic: latency of onset and descriptor patterns related to different injuries. Pain 1982; 14: 33-43.
29 Nair HP, Young LJ. Vasopressin and pair-bond formation: Genes to brain to behavior. Physiology 2004; 21: 146-152.
30 Plassmann H, Weber B. Individual differences in marketing placebo effects: Evidence from brain imaging and behavioral experiments. Journal of Marketing Research 2015; 52: 493-510.
31 Rilling JK, Demarco AC, Hackett PD, Chen X, Gautam P, Stair S. et al. Sex differences in the neural and behavioral response to intranasal oxytocin and vasopressin during human social interaction. Psychoneuroendocrinology 2014; 39: 237-248.
32 Schafer SM, Colloca L, Wager TD. Conditioned placebo analgesia persists when subjects know they are receiving a placebo. The Journal of Pain 2015; 16: 412-420.
33 Spitzer M. Vertrauen schnuppern. Nervenheilkunde 2005; 24: 522-523.
34 Spitzer M. Hormone zur Hochzeit. Gentest für Treue, Impfung gegen Scheidung. Nervenheilkunde 2010; 29: 179-182.
35 Spitzer M. Seelische Schmerzen tun auch weh. Schmerzmedizin 2012; 28 (04) 1-4.
36 Stewart-Williams S, Podd J. The placebo effect: Dissolving the expectancy versus conditioning debate. Psychological Bulletin 2004; 130: 324-340.
37 Thompson RR, George K, Walton JC, Orr SP, Benson J. Sex-specific influences of vasopressin on human social communication. PNAS 2006; 103: 7889-7894.
38 Tracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron 2007; 55: 377-391.
39 Ukkola LT, Onkamo P, Raijas P, Karma K, Järvelä I. Musical aptitude is associated with AVPR1A-Haplotypes. PLoS ONE 2009; 04: e5534.
40 Veenema AH, Beiderbeck DI, Lukas M, Neumann ID. Distinct correlations of vasopressin release within the lateral septum and thebed nucleus of the stria terminalis with the display of intermale aggression. Horm Behav 2010; 58: 273-281.
41 Walum H, Westberg L, Henningsson S, Neiderhise JM, Reiss D, Igl W, Ganiban JM, Spotts EL, Pedersen NL, Eriksson E, Paul PLichtenstein. Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans. PNAS 2008; 105: 14154-14156.
42 Weimer K, Colloca L, Enck P. Placebo effects in psychiatry: mediators and moderators. Lancet Psychiatry 2015; 02: 246-257.
43 Woo CW, Roy M, Buhle JT, Wager TD. Distinct brain systems mediate the effects of nociceptive input and self-regulation on pain. PLoS Biology 2015; 13: e1002036.
44 Yoshida W, Seymour B, Koltzenburg M, Dolan RJ. Uncertainty increases pain: evidence for a novel mechanism of pain modulation involving the periaqueductal gray. J Neurosci 2013; 33: 5638-5646.